Skip to main content

Table 1 Demographic data

From: Changes in pulse pressure variability during cardiac resynchronization therapy in mechanically ventilated patients

Age (years)

69 ± 6

Height (cm)

172 ± 9

Weight (kg)

81 ± 15

Dilated cardiomyopathy (n)

8

Ischemic heart disease (n)

11

LVEF (percentage)

24 ± 6

Beta-receptor blockers (n)

17

ACE inhibitors/Angiotensin II blockers (n)

18

Amiodarone (n)

7

Diuretics (n)

19

Cardiac glycosides (n)

7

  1. Data are reported as either mean ± standard deviation or as frequency distributions (n). ACE, angiotensin-converting enzyme; LVEF, left ventricular ejection fraction.